Opportunity ID: 308135

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-CA-18-012
Funding Opportunity Title: Limited Competition: AIDS and Cancer Specimen Resource (ACSR)(UM1 Clinical Trials Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.393 — Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Aug 09, 2018
Last Updated Date:
Original Closing Date for Applications: Nov 15, 2018
Current Closing Date for Applications: Nov 15, 2018
Archive Date: Dec 21, 2018
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. see the funding announcement for eligibility details

Additional Information

Agency Name: National Institutes of Health
Description: Through this limited competition Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) solicits a single application for the continuation of the AIDS and Cancer Specimen Resource (ACSR). The eligible applicant institutions (which are the two current NCI-supported ACSR lead institutions) are expected to maintain the cooperative group structure and the activities of the ACSR. The primary objective of the ACSR will be to acquire, store, and equitably distribute tumor tissues, biological fluids, and associated demographic data from patients with human immunodeficiency virus (HIV)-associated malignancies. In addition to serving acquired immunodeficiency syndrome (AIDS) and cancer researchers at large, the ACSR will specifically provide biorepository functions for another NCI supported initiative, the AIDS Malignancy Consortium (AMC). The AMC performs clinical trials research in the treatment and prevention of HIV-associated malignancies in the United States and Sub-Saharan Africa. As the AMC is currently expanding its agenda to include Latin America, it is expected that the ACSR will collaborate with the AMC to develop regional biorepository support for AMC activities in Latin American countries. The continuing ACSR must have appropriate strategies and capabilities to address several high priority areas of specimen acquisition including specific types of cancer (AIDS-defining as well as non-AIDS defining), types of biospecimens and accompanying clinical data, and biospecimens from geographic areas of interest.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-012.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E FORMS-E PKG00244334 Oct 15, 2018 Nov 15, 2018 View

Package 1

Mandatory forms

308135 RR_SF424_2_0-2.0.pdf

308135 PHS398_CoverPageSupplement_4_0-4.0.pdf

308135 RR_OtherProjectInfo_1_4-1.4.pdf

308135 PerformanceSite_2_0-2.0.pdf

308135 RR_KeyPersonExpanded_2_0-2.0.pdf

308135 RR_Budget_1_4-1.4.pdf

308135 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

308135 RR_SubawardBudget30_1_4-1.4.pdf

308135 PHS_AssignmentRequestForm_2_0-2.0.pdf

2025-07-09T20:02:53-05:00

Share This Post, Choose Your Platform!

About the Author: